Brief: Zura Bio Q3 EPS USD -0.18
13/11/2023 11:34
Nov 13 (Reuters) - Zura Bio Q3 EPS USD -0.18. * Q3 operating expenses USD 10.187 million * Q3 pretax profit USD -8.27 million * Q3 income from operations USD -10.187 million
Recent news on Zura Bio
See all newsZura Bio Ltd reports results for the quarter ended June 30 - Earnings Summary
Zura Bio Q2 net loss widens as R&D expenses rise
Zura Bio Ltd expected to post a loss of 20 cents a share - Earnings Preview
Brief: Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Zura Bio Expands Leadership Team With Appointment Of Muzammil Mustufa As Chief Business Officer